Research study Program year 2022 Source: CMS Open Payments

Multi-Center, Randomized, Double-Masked, Active Controlled, Parallel Group Study to Compare Perrigo's Brinzolamide Brimonidine Ophthalmic Suspension 1 percent to Simbrinza in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Both Eyes

ClinicalTrials.gov NCT04944290

Research payments

$2,662,071

87 payments

Through program year 2022, $2,662,071 in research payments was reported against Multi-Center, Randomized, Double-Masked, Active Controlled, Parallel Group Study to Compare Perrigo's Brinzolamide Brimonidine Ophthalmic Suspension 1 percent to Simbrinza in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Both Eyes, across 87 payments, paid by Padagis US LLC.

Paid by: Padagis US LLC
ClinicalTrials.gov: NCT04944290

By program year

2 rows

Year	Kind	Amount	Payments
2022	Research	$2,279,923	58
2021	Research	$382,147	29

Breakdown

Who paid Research payments · program years 2021–2022

Padagis US LLC $2,662,071 87 payments

Who received the money Research payments · program years 2021–2022

Central Florida Eye Associates Organisation paid for research $844,463 5 payments
Eye Research Foundation, Inc. Organisation paid for research $183,750 3 payments
Coastal Research Associates, LLC Organisation paid for research $153,100 5 payments
Total Eye Care, PA Organisation paid for research $141,350 4 payments
James D. Branch, MD Ophthalmology Organisation paid for research $139,500 4 payments
Orange County Ophthalmology Medical Group Organisation paid for research $132,650 4 payments
Global Research Management, Inc. Organisation paid for research $132,100 6 payments
AdvanceMed Clinical Research Organisation paid for research $125,330 7 payments
Piedmont Eye Center Organisation paid for research $123,604 5 payments
Clayton Eye Clinical Research, LLC Organisation paid for research $110,790 4 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Cite this record

“Multi-Center, Randomized, Double-Masked, Active Controlled, Parallel Group Study to Compare Perrigo's Brinzolamide Brimonidine Ophthalmic Suspension 1 percent to Simbrinza in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Both Eyes”, Who Paid My Doc, citing CMS Open Payments, program year 2022. https://www.whopaidmydoc.com/research-studies/multi-center-randomized-double-masked-active-controlled-parallel-group-study-to-compare-perrigo-s-brinzolamide-brimonidine-ophthalmic-suspension-1-percent-to-simbrinza-in-the-treatment-of-primary-open-angle-glaucoma-or-ocular-hypertension-in-both-eyes-213008409

Figures here may be reproduced with attribution and a link — see for journalists and researchers.